Journal of Hematology and Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 47.8 | Q1 | 100.0% | 11.824 | Q1 | 99.8% |
| 2024 | 40.4 | Q1 | 100.0% | 10.192 | Q1 | 99.7% |
| 2023 | 29.5 | Q1 | 96.8% | 7.522 | Q1 | 99.5% |
| 2022 | 28.5 | Q1 | 96.7% | 6.046 | Q1 | 99.4% |
| 2021 | 23.2 | Q1 | 95.4% | 4.241 | Q1 | 98.8% |
| 2020 | — | — | 4.305 | Q1 | 98.8% | |
| 2019 | — | — | 3.231 | Q1 | 98.1% | |
| 2018 | — | — | 2.960 | Q1 | 97.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1756-8722
country
GBcoverage
2008-2026